Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study. (2023)
Attributed to:
Data science and pharmacoepidemiology for outcome improvement in severe mental illness (DS-SMI)
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-40637-8
PubMed Identifier: 37591833
Publication URI: http://europepmc.org/abstract/MED/37591833
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723